Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets.
| Website: | www.clovisoncology.com |
| Main Phone: | +1 303 625-5000 |
| Address: | 5500 Flatiron Parkway |
| Address 2: | Suite 100 |
| State: | CO |
| City / Town: | Boulder |
| Country: | USA |
| Postal Code: | 80301 |
| Exchange: | NGS |
| Employees: | 309 |
| NAICS: | Pharmaceutical P |
| Last Price 77.50 | Change $ 0.73 | Change % 0.95 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 78.00 | Ask Size 100.00 |
| Open 77.90 | High 79.37 | Low 77.26 | Prev Close 76.77 |
| Last Trade | Volume 1.4 mi | 52 Wk Hi 99.45 | 52 Wk Low 25.81 |
| Market Cap 3.8 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 48,879,354.00 | EPS (TTM) -8.74 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 30 |
| Number of Buys | 0 | 2 |
| Number of Sells | 0 | 28 |
| Net Activity | 0 | -809888 |
| Last 10 Buys | Shares |
|---|---|
| Edward J. McKinley | 1,000 |
| Edward J. McKinley | 1,000 |
| Edward J. McKinley | 1,000 |
| Edward J. McKinley | 1,000 |
| Erle T. Mast | 1,000 |
| Thorlef Spickschen | 1,000 |
| Gillian C. Ivers-Read | 1,000 |
| Edward J. McKinley | 1,000 |
| Paul H. Klingenstein | 1,000 |
| James C. Blair | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Erle T. Mast | 1,000 |
| Lindsey Rolfe | 1,000 |
| Lindsey Rolfe | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 30 | 30 | 30 | 30 |
| Low Target Price Estimate | 14 | 14 | 14 | 14 |
| Mean Target Price Estimate | 21.17 | 20.29 | 19.5 | 21.17 |
| Standard Deviation | 6.05 | 5.99 | 6.16 | 6.05 |
| Date of Most Recent Estimate | 08/09/16 | 08/04/16 | 06/29/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 40 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2016-08-08 |
| SC 13G | Statement of beneficial ownership of common stock by certain persons | 5 | 2016-07-15 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-06-22 |
| CORRESP | Correspondence from the Filer to the SEC | 1 | 2016-06-20 |
| UPLOAD | Correspondence from the SEC to the Filer | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 3 | 4 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2.33 | 2.33 | 2.33 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
